Responding to the 10,000 new Australian jobs

PharmOut announced today that it will invest in a multimillion-dollar state of the art Medicinal Cannabis Academy to offer practical training in the growing and processing of Medicinal Cannabis into pharmaceutical dosage forms.

The Medicinal Cannabis Academy will expand PharmOut’s existing global leadership in the areas of Good Agricultural and Collection Practices (GACP), Good Manufacturing Practices (GMP), consulting and training. Commencing in the third quarter, the Academy will help cultivators, manufactures and job seekers in meeting the medicinal cannabis industry’s estimated demand for 10,000 new regional workers over the next two years.

Trevor Schoerie, PharmOut’s Managing Director commented “Medicinal Cannabis cultivation and processing is an exciting global phenomenon. Australia’s reputation for good agricultural practices and compliance, added to the favourable climate and land availability has seen hundreds of millions of dollars being invested into the region. Given this is a brand-new industry, there is a substantial knowledge gap. Our plan is to help cultivators, manufacturers and their workforce learn about propagation, cultivation, harvesting and processing and to help them meet the stringent regulatory standards required for both local and export markets.”  In looking to leverage early global mover advantage, Medicinal Cannabis companies are moving quickly to secure large export contracts.

Maria Mylonas, PharmOut’s Learning and Development Director, is equally excited about expanding PharmOut’s existing educational services, saying “PharmOut is frequently asked for guidance by the industry looking to recruit staff experienced in cannabis cultivation and processing under a framework of Good Agricultural Collection Practices (GACP) and Good Manufacturing Practices (GMP) as required by the regulators. At the same time, there are job seekers looking for opportunities to establish a career in this interesting growth sector. PharmOut has over 10 years’ experience in training Pharmaceutical industry employees and the Academy is a natural extension of what we do.”

According to a report by Global Market Insights, the global medicinal cannabis industry was estimated to be worth more than US$ 11 Billion in 2017 and projected to surpass $US 55 billion by 2024.

Australia legalised cannabis for medicinal use in October 2016 creating strong interest from international and local investors. There is currently an estimated investment of over 2 million square meters in new greenhouse capacity in Australia, specifically focused on meeting the global market demand for Medicinal Cannabis. For example, Canadian Company, Asterion, recently announced the Australian Government Awarding of Major Project Status for their Australian entity’s $450 million Toowoomba Medicinal Cannabis Project. Asterion estimates the requirement for a full-time workforce of 800 as well as an additional 300 part time and shift-based positions. The project is planned to commence in the last quarter of 2019.

About PharmOut:

Founded in 2006, PharmOut is an experienced professional consultancy specialising in supporting the medicinal cannabis and pharmaceutical manufacturing industries with offices in Australia, Hong Kong, New Zealand, South Africa and the United Kingdom and United States.

PharmOut regularly guides clients through the rigorous licensing, permitting, GACP and GMP requirements of various international agencies.